Skip to main content

Solvay, Ashland complete buys

Two recent acquisitions that are both largely focused in the personal care arena were both completed almost simultaneously. Solvay completed the sale of its amphoteric surfactant business to OpenGate Capital, while Ashland finalised that of the personal care business of Schülke & Mayr from investment firm EQT.

Feature Article - Quietly weathering the storm

Carolyn Buller of Squire Patton Boggs takes a look back at a year like no other in chemicals

Squire Patton Boggs (SPB), a global law firm, has about one third of the top 60 chemical companies as clients and is constantly speaking with the industry about ongoing trends. The COVID-19 pandemic has made forecasting an even more treacherous business than ever and it is always hard to generalise over so broad a concept as speciality chemicals. ‘Specialities’ are a never-ending game – everything is or was a speciality until, one day, it no longer is.

Ashland makes board changes in fight against ‘activist’

Speciality chemicals giant Ashland has announced that, in consultation with one of its largest shareholders, the independent investment manager Neuberger Berman, it will add two new independent board members – yet to be found - and appoint a lead independent director and new board committee chairs at its annual meeting on 8 February.

Subscribe to Ashland

 

SC newsletter banner